Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as CSO by bizlift | Oct 3, 2019 | Portfolio News, Verve Press Releases
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board by bizlift | Sep 16, 2019 | Portfolio News, Verve Press Releases
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV by bizlift | May 7, 2019 | Portfolio News, Verve Press Releases
